XML 141 R124.htm IDEA: XBRL DOCUMENT v3.22.4
Quarterly Results of Operations (unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Quarterly Financial Data [Abstract]                      
Revenue $ 382,432 $ 352,585 $ 319,939 $ 297,057 $ 248,358 $ 222,471 $ 222,057 $ 215,071      
Total operating expenses 384,310 339,634 324,572 299,855 260,572 229,052 229,728 231,016      
Loss from continuing operations (11,349) 2,123 (4,125) (5,350) 3,053 (13,040) (9,107) (11,190)      
Net loss from discontinued operations, net of tax 0 0 (463) 0 (8,700) 0 0 1,383 $ (463) $ (7,317) $ (6,074)
Net loss attributable to common shareholders of Evolent Health, Inc - Basic (11,349) 2,123 (4,588) (5,350) (5,647) (13,040) (9,107) (9,807) (19,164) (37,601) (334,246)
Net loss attributable to common shareholders of Evolent Health, Inc. - Diluted $ (11,349) $ 2,123 $ (4,588) $ (5,350) $ (5,647) $ (13,040) $ (9,107) $ (9,807) $ (19,164) $ (37,601) $ (334,246)
Loss per common share                      
Continuing operations, basic (in dollars per share) $ (0.11) $ 0.02 $ (0.05) $ (0.06) $ 0.03 $ (0.15) $ (0.11) $ (0.13) $ (0.20) $ (0.35) $ (3.86)
Continuing operations, diluted (in dollars per share) (0.11) 0.02 (0.05) (0.06) 0.03 (0.15) (0.11) (0.13) (0.20) (0.35) (3.86)
Discontinued operations, basic (in dollars per share) 0 0 0 0 (0.09) 0 0 0.01 0 (0.09) (0.08)
Discontinued operations, diluted (in dollars per share) $ 0 $ 0 $ 0 $ 0 $ (0.09) $ 0 $ 0 $ 0.01 $ 0 $ (0.09) $ (0.08)